US Broker Ratings

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 46% Upside Potential in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is carving out a significant niche in the healthcare sector with its pioneering approach to precision medicine oncology. Based in South..

Arcutis Biotherapeutics, Inc. (ARQT): Analyst Ratings Signal a Promising 41% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing attention in the biotechnology sector with a notable market cap of $3.3 billion, underscoring its significant role within the..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: 67.95% Potential Upside in the Biotech Sector

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with its promising pipeline in the biotechnology sector and an impressive potential upside of 67.95% based..

ICU Medical, Inc. (ICUI) Investor Outlook: Strong Buy Ratings and 17.98% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI) stands as a formidable player in the healthcare sector, specializing in the development and manufacturing of innovative medical products for infusion..

MoonLake Immunotherapeutics (MLTX) Stock Report: Potential 167% Upside in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising therapeutic developments and a staggering potential upside of..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Unveiling a 234% Potential Upside in the Biotech Sector

In the rapidly evolving biotechnology sector, Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out with a promising future, underscored by an impressive potential upside of 234.19%. As..

Mesoblast Limited (MESO) Stock Analysis: Exploring the 159% Upside Potential

Investors with an appetite for high-risk, high-reward opportunities in the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) an intriguing prospect. With a market capitalization of..

Brookdale Senior Living Inc. (BKD): Analyst Ratings Point to 86% Potential Upside

Investors eyeing the healthcare sector may find Brookdale Senior Living Inc. (NYSE: BKD) an intriguing proposition, especially with a potential upside of 86.36% indicated by recent..

CG Oncology, Inc. (CGON) Stock Analysis: A 44% Upside Potential Amidst Promising Biotech Innovations

Investors with a keen interest in the biotechnology sector should take a closer look at CG Oncology, Inc. (NASDAQ: CGON), a company rooted in the healthcare..

AtriCure, Inc. (ATRC) Stock Analysis: Navigating Potential with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its innovative solutions..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Biotechnology Innovator Poised for 114% Upside

Investors with an eye on the biotech sector may find Celldex Therapeutics, Inc. (NASDAQ: CLDX) a compelling opportunity. The company, which operates in the healthcare sector..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 65.79% Potential Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology firm, has captured investor attention with its ambitious focus on developing targeted therapies for autoimmune diseases. With a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Report: Analyzing a Promising 102% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering biopharmaceutical company focused on neuroscience, presents a compelling opportunity for investors eyeing the burgeoning biotechnology sector. With an impressive..

GoodRx Holdings, Inc. (GDRX): Investor Outlook on Healthcare Savings Innovator with a 13.51% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a notable player in the healthcare information services industry, operating within the broader healthcare sector. As a U.S.-based entity,..

Progyny, Inc. (PGNY) Stock Analysis: Unveiling a 22.79% Potential Upside in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) is a standout player in the healthcare plans industry, focusing on fertility and family-building benefits. With a market capitalization of $2.15 billion,..

Agios Pharmaceuticals, Inc. (AGIO) Stock Report: Unpacking a 49% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a key player in the biotechnology sector, is currently capturing the attention of investors with a notable potential upside of 49.25%,..

Evotec SE (EVO) Stock Analysis: Unveiling a 203% Potential Upside Amidst Strategic Collaborations

For investors looking to explore opportunities in the healthcare sector, Evotec SE (EVO) presents a compelling case with a remarkable potential upside of 203.35%. Despite facing..

Haemonetics Corporation (HAE) Stock Analysis: Riding High with a 52-Week Peak and Promising Analyst Ratings

Haemonetics Corporation (NYSE: HAE), a major player in the medical devices sector, is currently capturing investor attention with its impressive market performance. As of the latest..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the Nearly 100% Potential Upside

In the intriguing world of biotechnology, few companies are as captivating as Janux Therapeutics, Inc. (NASDAQ: JANX). This San Diego-based biopharmaceutical firm is making headlines with..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A 24.6% Potential Upside in the Thriving Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is a healthcare sector standout, specifically within the biotechnology industry, with a market capitalization of $2.23 billion. Operating out of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds